Vijayalaxmi Gupta

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “The Tie2 antagonist rebastinib reduces ovarian cancer growth in a syngeneic murine model”.

The Tie2 antagonist rebastinib reduces ovarian cancer growth in a syngeneic murine model

BMC Cancer(2025)10.1186/s12885-025-13640-z

N/A

0.104DataRank · unranked

1 citations

Katherine F. Roby, Harsh B. Pathak, Andrew K. Godwin, Sumedha Gunewardena, Dineo Khabele +1 more

Ascites-induced compression alters the peritoneal microenvironment and promotes metastatic success in ovarian cancer

Scientific Reports(2020)10.1038/s41598-020-68639-2

N/A

0DataRank · unranked

47 citations

Allison Young, Carlysa Oyama, Alejandro ClaureDeLaZerda, Yueying Liu, Matthew J. Ravosa +5 more

Panobinostat enhances olaparib efficacy by modifying expression of homologous recombination repair and immune transcripts in ovarian cancer

Neoplasia(2021)10.1016/j.neo.2021.12.002

N/A

0DataRank · unranked

29 citations

Vijayalaxmi Gupta, Qi Liu, Fiona E. Yull, Marta A. Crispens, Dineo Khabele +1 more

Targeting RAD52 overcomes PARP inhibitor resistance in preclinical Brca2 -deficient ovarian cancer model

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.09.24.678351

N/A

0DataRank · unranked

0 citations

Vijayalaxmi Gupta, Bisiayo Fashemi, Moreniola Akande, Elizabeth Babu, Prasanth Thuthika +17 more